Stock listing
Munich:5LU Simris Group AB Aktie
German listing (Munich) of Simris Group AB · home listing Stockholm:SIMRISB
Follow Simris Group AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:SIMRIS_B
0.087 SEK -0.009 (-9.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:SIMRIS_B
- Day range
- 0.080 – 0.095 SEKNov 20, 2026
- Volume
- 11,935 sharesNov 20, 2026
- Market cap
- 118.0M SEKAt the close on Nov 20, 2026 · price × 1.35B shares outstanding
- 52-week range
- 0.040 – 0.195 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 23,675 SEKMedian day 91,009 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Frankfurt:5LU | €0.0060 EUR | +0.0020 (+50.0%) | — | €0.0030 | €0.0060 | €0.0030 | €0.0040 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:SIMRIS_B · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.087 | -0.009 | -9.0% | 0.080 | 0.095 | 0.080 | 11,935 | |
| 0.096 | +0.007 | +7.9% | 0.099 | 0.099 | 0.075 | 165,816 | |
| 0.089 | +0.002 | +2.3% | 0.088 | 0.089 | 0.088 | 72,138 | |
| 0.087 | 0.000 | -0.5% | 0.087 | 0.087 | 0.070 | 105,817 | |
| 0.087 | +0.012 | +16.2% | 0.099 | 0.099 | 0.080 | 376,619 | |
| 0.075 | -0.020 | -20.8% | 0.095 | 0.096 | 0.050 | 1,502,138 | |
| 0.095 | -0.007 | -6.9% | 0.110 | 0.110 | 0.092 | 305,591 | |
| 0.102 | -0.010 | -8.5% | 0.114 | 0.114 | 0.102 | 106,453 | |
| 0.112 | -0.005 | -4.3% | 0.115 | 0.115 | 0.102 | 132,424 | |
| 0.117 | +0.003 | +2.2% | 0.114 | 0.118 | 0.101 | 287,366 | |
| 0.114 | -0.006 | -5.0% | 0.118 | 0.121 | 0.114 | 47,443 | |
| 0.120 | +0.001 | +0.8% | 0.119 | 0.128 | 0.113 | 1,367,040 | |
| 0.119 | +0.006 | +5.3% | 0.113 | 0.119 | 0.113 | 25,935 | |
| 0.113 | -0.008 | -6.6% | 0.121 | 0.121 | 0.113 | 78,608 | |
| 0.121 | -0.004 | -3.2% | 0.121 | 0.122 | 0.111 | 24,887 | |
| 0.125 | +0.004 | +2.9% | 0.122 | 0.125 | 0.110 | 42,261 | |
| 0.122 | +0.002 | +1.7% | 0.115 | 0.127 | 0.113 | 39,412 | |
| 0.120 | -0.002 | -1.6% | 0.126 | 0.126 | 0.113 | 30,986 | |
| 0.122 | -0.003 | -2.4% | 0.124 | 0.128 | 0.111 | 254,667 | |
| 0.125 | +0.006 | +5.1% | 0.120 | 0.138 | 0.110 | 379,804 | |
| 0.119 | -0.004 | -3.3% | 0.127 | 0.130 | 0.112 | 247,602 | |
| 0.123 | -0.004 | -3.2% | 0.121 | 0.125 | 0.120 | 127,219 | |
| 0.127 | +0.008 | +6.3% | 0.119 | 0.127 | 0.119 | 40,109 | |
| 0.119 | -0.009 | -7.0% | 0.111 | 0.128 | 0.111 | 432,066 | |
| 0.128 | +0.008 | +6.7% | 0.129 | 0.129 | 0.109 | 24,604 | |
| 0.120 | +0.001 | +0.4% | 0.108 | 0.147 | 0.108 | 792,171 | |
| 0.120 | -0.001 | -0.4% | 0.120 | 0.120 | 0.108 | 22,251 | |
| 0.120 | -0.003 | -2.0% | 0.115 | 0.122 | 0.108 | 163,903 | |
| 0.123 | +0.011 | +9.9% | 0.121 | 0.147 | 0.112 | 982,568 | |
| 0.112 | +0.004 | +3.7% | 0.118 | 0.120 | 0.108 | 236,483 | |
| 0.108 | -0.021 | -16.0% | 0.120 | 0.120 | 0.108 | 227,983 | |
| 0.128 | +0.016 | +14.3% | 0.124 | 0.140 | 0.107 | 559,023 | |
| 0.112 | -0.012 | -9.7% | 0.124 | 0.124 | 0.112 | 54,549 | |
| 0.124 | +0.014 | +12.7% | 0.111 | 0.124 | 0.111 | 183,219 | |
| 0.110 | -0.006 | -5.2% | 0.124 | 0.124 | 0.099 | 70,288 | |
| 0.116 | +0.002 | +1.8% | 0.125 | 0.127 | 0.116 | 7,310 | |
| 0.114 | -0.004 | -3.4% | 0.110 | 0.123 | 0.110 | 56,863 | |
| 0.118 | +0.013 | +12.9% | 0.119 | 0.119 | 0.103 | 113,247 | |
| 0.105 | +0.001 | +0.5% | 0.110 | 0.120 | 0.105 | 82,086 | |
| 0.104 | -0.014 | -11.9% | 0.118 | 0.118 | 0.102 | 126,257 | |
| 0.118 | +0.002 | +1.7% | 0.125 | 0.125 | 0.116 | 18,319 | |
| 0.116 | +0.001 | +0.9% | 0.116 | 0.125 | 0.116 | 348,051 | |
| 0.115 | +0.012 | +11.1% | 0.118 | 0.120 | 0.098 | 81,557 | |
| 0.104 | -0.014 | -11.9% | 0.113 | 0.119 | 0.098 | 87,102 | |
| 0.118 | +0.000 | +0.4% | 0.118 | 0.120 | 0.117 | 55,548 | |
| 0.117 | -0.002 | -2.1% | 0.115 | 0.119 | 0.093 | 62,367 | |
| 0.120 | +0.002 | +2.1% | 0.119 | 0.120 | 0.093 | 164,359 | |
| 0.117 | +0.007 | +6.4% | 0.113 | 0.120 | 0.100 | 443,455 | |
| 0.110 | +0.020 | +22.8% | 0.090 | 0.121 | 0.090 | 1,334,855 | |
| 0.090 | +0.003 | +3.7% | 0.086 | 0.090 | 0.086 | 3,013 | |
| 0.086 | -0.004 | -4.0% | 0.090 | 0.090 | 0.086 | 46,937 | |
| 0.090 | +0.000 | +0.2% | 0.090 | 0.090 | 0.086 | 374,549 | |
| 0.090 | +0.000 | +0.2% | 0.090 | 0.100 | 0.090 | 388,790 | |
| 0.090 | -0.005 | -5.1% | 0.095 | 0.095 | 0.086 | 216,763 | |
| 0.094 | -0.002 | -2.5% | 0.094 | 0.097 | 0.086 | 31,863 | |
| 0.097 | -0.002 | -2.0% | 0.090 | 0.099 | 0.086 | 94,916 | |
| 0.099 | +0.001 | +0.8% | 0.098 | 0.099 | 0.086 | 59,272 | |
| 0.098 | -0.001 | -1.4% | 0.098 | 0.099 | 0.089 | 59,271 | |
| 0.099 | +0.004 | +4.6% | 0.092 | 0.108 | 0.085 | 146,216 | |
| 0.095 | -0.005 | -5.0% | 0.110 | 0.110 | 0.095 | 85,586 | |
| 0.100 | +0.004 | +4.2% | 0.100 | 0.110 | 0.096 | 81,048 | |
| 0.096 | -0.004 | -3.6% | 0.100 | 0.100 | 0.094 | 20,010 | |
| 0.100 | 0.000 | -0.2% | 0.100 | 0.100 | 0.092 | 55,011 | |
| 0.100 | +0.001 | +1.2% | 0.087 | 0.100 | 0.087 | 249,744 | |
| 0.099 | +0.006 | +6.7% | 0.099 | 0.099 | 0.093 | 22,296 | |
| 0.092 | +0.000 | +0.4% | 0.099 | 0.099 | 0.092 | 12,727 |
- Ticker
- Munich:5LU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news
Holders of warrants in Simris Group AB (publ) have declared their intention to exercise 220 million warrants amounting to total proceeds of MEUR 1
Jul 6, 2026
Closed 0.083 (-6.6%) on Jul 7, 2026
Bulletin from Simris Group AB’s annual general meeting
Jun 24, 2026
Closed 0.087 (+3.6%) on Jun 25, 2026
Correction: Notice of the Annual General Meeting of Simris Group AB (publ)
May 21, 2026
Closed 0.08 (-7.8%) on May 22, 2026
Simris Group interim report january-March 2026
May 13, 2026
Closed 0.101 (-9.0%) on May 13, 2026
Simris Group Advances Asset Divestment Process With Two Prospective Buyers
May 12, 2026
Closed 0.111 (+12.6%) on May 12, 2026
Simris Group publishes its annual report for 2025
Apr 15, 2026
Closed 0.089 (-5.1%) on Apr 15, 2026
Simris Evaluating Options To Expand Its ADC-Payload Development Programme
Mar 19, 2026
Closed 0.117 (+25.3%) on Mar 19, 2026
Simris Updates On Divestment Of Its Assets
Mar 11, 2026
Closed 0.116 (+1.8%) on Mar 11, 2026
Simris Q4 EBIT Loss Narrows To SEK 8.4 Million
Mar 2, 2026
Closed 0.106 (+11.6%) on Mar 2, 2026
SIMRIS_B: Losses narrowed in 2025, but continued operations depend on securing new financing
Feb 28, 2026
Closed 0.106 (+11.6%) on Mar 2, 2026
Simris Group AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 21 in all · newest Jul 6, 2026 · oldest 2024
Where Simris Group AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:SIMRISB · Home listing | Stockholm | Sweden | SEK |
| Frankfurt:5LU | Frankfurt | Germany | EUR |
| gettex:5LU | gettex | Germany | EUR |
| Munich:5LU · This page | Munich | Germany | EUR |
Valuation
EV/sales 144× against a median of 4.8×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 199.7M SEK
- P/E
- Loss
- EV/sales
- 144×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 154×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 117×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Simris Group AB Class B · OMXSTO:SIMRIS_B | US$11.54M | US$19.53M | n/a | 144× | n/a | 154× | n/a | 117× | n/a |
| BioCardia, Inc. · NASDAQ:BCDA | US$11.88M | US$10.22M | n/a | n/a | n/a | 14.2× | n/a | 0.7× | 0.42 |
| Xintela AB · OMXSTO:XINT | US$11.88M | US$11.81M | n/a | 39.8× | n/a | n/a | n/a | n/a | n/a |
| Pluri Inc. · NASDAQ:PLUR | US$11.85M | US$38.65M | n/a | 26.5× | n/a | n/a | n/a | n/a | 0.53 |
| Synlogic Inc · OTC:SYBX | US$11.76M | US$201,442 | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 0.50 |
| Imugene Ltd · ASX:IMU | US$11.74M | US$14.16M | n/a | n/a | n/a | 2.0× | n/a | 0.7× | n/a |
| Radiopharm Theranostics Limited · ASX:RAD | US$11.59M | US$8.85M | n/a | 4.8× | n/a | 0.7× | n/a | 0.0× | n/a |
| Aelis Farma SA · EURONEXT:AELIS | US$11.55M | US$9.09M | n/a | 4.0× | n/a | 4.5× | −308.7% | 1.9× | n/a |
| Dyadic International, Inc. · NASDAQ:DYAI | US$11.51M | US$12.03M | n/a | 3.9× | n/a | n/a | −226.9% | n/a | 1.12 |
| Psyence Biomedical Ltd. · NASDAQ:PBM | US$11.33M | US$4.18M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 0.90 |
| Medicenna Therapeutics Corp. · TSX:MDNA | US$11.26M | US$7.37M | n/a | n/a | n/a | 9.7× | n/a | 0.1× | 1.36 |
| Median of the others | US$11.66M | US$9.66M | 4.8× | 2.0× | −267.8% | 0.1× | 0.72 |
Team and board
| Officer | Role |
|---|---|
| Daniel Kubitza | Interim CEO of Simris Group AB |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 5, 2024 · Before open | −11.2% |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Class B shares on exercise of warrants of series 2025/2027 and 2026/2027 Announced: €1 · SEK 0.05 a share | Jul 6, 2026 | US$1 |
| Private placement of units consisting of class B shares and warrants Update: SEK 0.05 a unit | Jan 19, 2026 | |
| Private placement of class B shares Announced: SEK 0.05 a share Insiders: Directed issue to managers who have entered into loan agreements with the Company | Jan 19, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.61M | 2.89M | 4.35M | 4.08M | 6.14M | 2.17M | 1.74M | 761.8K | 851.6K | 726.2K |
| Cost of revenue | 33.0M | 1.67M | 2.35M | 4.82M | 8.20M | 4.92M | 3.13M | 1.06M | -1.62M | 1.47M |
| Gross profit | -31.3M | 1.22M | 2.01M | -742.0K | -2.07M | -2.75M | -1.39M | -296.7K | 2.47M | -741.8K |
| Research and development | 90.0K | 98.0K | 433.0K | 432.5K | ||||||
| Selling, general and administrative | 5.83M | 7.43M | 9.85M | 10.9M | 12.3M | 10.7M | 9.52M | 9.58M | 8.94M | 7.63M |
| Operating income | -31.3M | -34.7M | -36.6M | -24.7M | -28.9M | -23.7M | -24.6M | -22.7M | -22.6M | -18.8M |
| Depreciation and amortization | 14.0M | 14.9M | 14.3M | 6.65M | 2.92M | 3.03M | 3.13M | 3.48M | 3.48M | 1.59M |
| EBITDA | -17.3M | -19.8M | -22.4M | -18.0M | -26.0M | -20.7M | -21.5M | -19.2M | -19.1M | -17.2M |
| Interest expense | 441.0K | 3.50M | 3.99M | 1.11M | 616.0K | 1.84M | 2.38M | 1.32M | 354.3K | 570.3K |
| Income before tax | -30.0M | -38.2M | -40.6M | -25.8M | -28.3M | -25.5M | -27.0M | -24.0M | -23.0M | -19.3M |
| Income tax | -3.19M | -3.57M | -3.32M | -1.34M | 13.0K | 67.0K | -94.0K | -18.0K | 14.2K | 22.3K |
| Net income | -26.8M | -34.6M | -37.3M | -24.4M | -28.4M | -25.6M | -26.9M | -24.0M | -23.0M | -19.3M |
| Earnings per share, basic | -0.03 | -0.10 | -0.16 | -0.16 | -0.24 | -0.23 | -1.20 | -0.97 | -1.14 | -1.04 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.47M | 1.95M | 5.67M | 3.99M | 961.0K | 16.5M | 7.86M | 4.42M | 7.43M | 32.1M |
| Receivables | 13.9M | 503.0K | 2.18M | 945.0K | 728.0K | 777.0K | 1.41M | 698.8K | 873.9K | 1.03M |
| Inventory | 1.08M | 509.0K | 1.09M | 2.26M | 3.35M | 8.82M | 10.9M | 9.96M | 7.39M | 2.30M |
| Current assets | 16.5M | 3.05M | 9.21M | 7.40M | 5.78M | 28.1M | 20.4M | 15.4M | 16.7M | 35.5M |
| Property, plant and equipment | 11.4M | 15.0M | 20.5M | 22.4M | 23.4M | 26.4M | 29.1M | 32.1M | 35.0M | 37.9M |
| Total assets | 148.4M | 157.1M | 174.6M | 185.7M | 29.2M | 57.1M | 52.2M | 49.8M | 54.4M | 76.4M |
| Accounts payable | 1.31M | 1.82M | 1.83M | 939.0K | 1.10M | 1.94M | 1.50M | 1.50M | 1.90M | 636.5K |
| Current liabilities | 25.0M | 16.0M | 14.3M | 23.9M | 9.09M | 6.92M | 13.8M | 5.66M | 5.88M | 4.60M |
| Long-term debt | 1.27M | 1.37M | 1.46M | 1.56M | 1.81M | 2.65M | 3.36M | 4.34M | 5.79M | 6.41M |
| Total debt | 87.7M | 2.04M | 2.67M | 2.13M | 3.13M | 3.99M | 4.70M | 5.69M | 6.72M | 7.23M |
| Total liabilities | 148.9M | 151.4M | 148.9M | 162.7M | 11.0M | 9.64M | 17.2M | 10.1M | 11.7M | 11.0M |
| Shareholders' equity | -470.0K | 5.64M | 25.6M | 23.0M | 18.2M | 47.4M | 35.0M | 39.8M | 42.7M | 65.3M |
| Shares outstanding | 842.1M | 348.1M | 228.6M | 148.7M | 119.1M | 111.2M | 22.5M | 24.6M | 20.2M | 18.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -16.0M | -18.0M | -36.4M | -18.2M | -18.1M | -19.5M | -17.3M | -22.3M | -23.6M | -18.6M |
| Capital spending | -16.0M | -613.0K | -1.61M | -22.4M | -253.0K | -286.0K | -356.0K | -169.9K | -301.1K | -15.6M |
| Free cash flow | -16.3M | -18.6M | -38.0M | -40.6M | -18.4M | -19.8M | -17.7M | -22.4M | -23.9M | -34.2M |
| Cash from investing | -224.0K | -613.0K | -1.61M | -22.4M | -253.0K | -286.0K | -356.0K | -169.9K | -301.1K | -15.6M |
| Cash from financing | 15.8M | 14.9M | 39.6M | 43.6M | 2.84M | 28.4M | 21.1M | 19.4M | -781.4K | 40.7M |
| Share buybacks | 13.9M | 39.3M | 28.1M | 201.0K | 36.9M | 22.1M | 21.1M | 337.8K | 46.0M | |
| Change in cash | -481.0K | -3.72M | 1.67M | 3.03M | -15.6M | 8.65M | 3.44M | -3.01M | -24.7M | 6.46M |
Cap table
Built by 6ix from Simris Group AB Class B’s releases · as of Jul 6, 2026
- Common shares
- 1,349,793,273
- Fully diluted
- 1,349,793,273
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,349,793,273 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,349,793,273 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel Kubitza | Interim CEO of Simris Group AB · Since at least Jul 6, 2026 |
Log in to ask 6ix AI your own questions about Simris Group AB.